Brain lipidology: why lower LDL cholesterol protects cognitive and cardiovascular health

The belief that reducing LDL cholesterol injures the brain is false, according to cardiologist Tom Dayspring in his analysis of brain lipidology. The brain synthesizes its own cholesterol independently through lipid homeostasis mechanisms regulated by APOE and other transport proteins, meaning LDL-lowering drugs (statins, PCSK9 inhibitors) do not cross the blood-brain barrier in clinically significant amounts. This distinction is critical because elevated systemic cholesterol increases cardiovascular disease and neurodegeneration risk, while local brain cholesterol remains protected. For the longevity-conscious reader, this means efforts to maintain low LDL through lipid therapy do not compromise cognitive health; instead, they simultaneously reduce vascular inflammation that accelerates brain aging.